Peng Jiang

17.4k total citations · 4 hit papers
92 papers, 8.3k citations indexed

About

Peng Jiang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Peng Jiang has authored 92 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 27 papers in Pulmonary and Respiratory Medicine and 23 papers in Oncology. Recurrent topics in Peng Jiang's work include Cancer Immunotherapy and Biomarkers (17 papers), Intracranial Aneurysms: Treatment and Complications (13 papers) and Cancer Genomics and Diagnostics (11 papers). Peng Jiang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (17 papers), Intracranial Aneurysms: Treatment and Complications (13 papers) and Cancer Genomics and Diagnostics (11 papers). Peng Jiang collaborates with scholars based in China, United States and Hong Kong. Peng Jiang's co-authors include X. Shirley Liu, Bo Li, Jingxin Fu, Myles Brown, Kai W. Wucherpfennig, Shengqing Gu, Xihao Hu, Ziyi Li, Deng Pan and Nicole Traugh and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Peng Jiang

85 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

2018 3.2k citations Peng Jiang, Shengqing Gu et al. profile →
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy

2016 1.6k citations Bo Li, Taiwen Li et al. profile →
Large-scale public data reuse to model immunotherapy response and resistance

2020 697 citations Jingxin Fu, Wubing Zhang et al. profile →
A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing

2018 567 citations Deng Pan, Aya Kobayashi et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peng Jiang China	28	4.4k	3.6k	3.3k	2.5k	2.1k	92	8.3k
Kosuke Yoshihara Japan	31	4.6k 1.1×	3.8k 1.1×	3.1k 0.9×	3.3k 1.3×	1.8k 0.9×	103	9.1k
Hoon Kim United States	20	4.7k 1.1×	3.7k 1.0×	2.8k 0.9×	3.6k 1.4×	1.5k 0.7×	35	8.3k
Joel W. Neal United States	37	2.6k 0.6×	3.7k 1.0×	4.0k 1.2×	2.8k 1.1×	783 0.4×	259	7.8k
Priti Lal United States	34	2.5k 0.6×	2.4k 0.7×	3.0k 0.9×	2.0k 0.8×	1.3k 0.6×	128	6.7k
Emmanuel Martínez Mexico	7	3.3k 0.8×	3.5k 1.0×	2.4k 0.7×	2.5k 1.0×	1.3k 0.6×	13	6.2k
Seiji Yano Japan	46	4.3k 1.0×	4.9k 1.4×	5.2k 1.6×	1.6k 0.6×	840 0.4×	253	9.6k
Yichao Sun United States	2	7.4k 1.7×	2.9k 0.8×	3.4k 1.0×	3.5k 1.4×	1.1k 0.5×	3	10.8k
Gideon Dresdner United States	3	7.4k 1.7×	2.9k 0.8×	3.4k 1.0×	3.5k 1.4×	1.1k 0.5×	3	10.8k
Florent Petitprez France	23	2.4k 0.6×	2.2k 0.6×	3.7k 1.1×	1.6k 0.6×	3.0k 1.4×	36	7.0k
Lukas C. Amler United States	46	5.0k 1.1×	2.8k 0.8×	4.8k 1.5×	2.7k 1.0×	656 0.3×	98	9.5k

Countries citing papers authored by Peng Jiang

Since Specialization

Citations

This map shows the geographic impact of Peng Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Jiang more than expected).

Fields of papers citing papers by Peng Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Jiang. The network helps show where Peng Jiang may publish in the future.

Co-authorship network of co-authors of Peng Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Jiang. A scholar is included among the top collaborators of Peng Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Jiang. Peng Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiang, Peng, et al.. (2025). LncRNA ‐ HCP5 Regulates KLF5 by ceRNA and m6A Pathways to Inhibit the Progression of Osteoarthritis. International Journal of Rheumatic Diseases. 28(1). e70035–e70035.

Zhang, Shaoqing, et al.. (2025). LncRNA Rmst-driven DNMT3A mRNA stabilization through HuR: implications for neuropathic pain therapy. European journal of medical research. 30(1). 993–993.

Xiao, Yu, et al.. (2025). Immunological Safety Evaluation of Exosomes Derived From Human Umbilical Cord Mesenchymal Stem Cells in Mice. Stem Cells International. 2025(1). 9986368–9986368. 2 indexed citations

Jiang, Qun, et al.. (2024). Inhibition of Dorsal Root Ganglia Transient Receptor Potential Ankyrin 1 Upregulation Contributes to the Protective Effect of Morphine Against Gastric Mucosal Damage Induced by Water-Immersion Restraint Stress. The Turkish Journal of Gastroenterology. 35(6). 453–464. 1 indexed citations

Yan, Xiao-Chen, Peng Jiang, Changqing Li, et al.. (2024). Intravenous immunoglobulin ameliorates doxorubicin-induced intestinal mucositis by inhibiting the Syk/PI3K/Akt axis and ferroptosis. APOPTOSIS. 30(3-4). 734–750. 3 indexed citations

Sinha, Sanju, Rahulsimham Vegesna, Sumit Mukherjee, et al.. (2024). PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors. Nature Cancer. 5(6). 938–952. 48 indexed citations

Zhou, Hong-Yu, Licheng Tan, Baifeng Zhang, et al.. (2024). GPRC5A promotes lung colonization of esophageal squamous cell carcinoma. Nature Communications. 15(1). 9950–9950. 2 indexed citations

Xiao, Yu, et al.. (2024). Non-Clinical Safety Evaluation of Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells in Cynomolgus Monkeys. International Journal of Nanomedicine. Volume 19. 4923–4939. 13 indexed citations

Jiang, Peng, et al.. (2024). Comparison of the treatment strategies for symptomatic chronic internal carotid artery occlusion. Journal of Vascular Surgery. 81(2). 494–504.e2.

10.

Zhang, Xuchen, Chuantao Zhang, Helei Hou, et al.. (2023). Neoadjuvant PD-1 blockade plus chemotherapy versus chemotherapy alone in locally advanced stage II-III gastric cancer: A single-centre retrospective study. Translational Oncology. 31. 101657–101657. 13 indexed citations

11.

Li, Wenqiang, et al.. (2021). Endovascular treatment of vertebral and basilar artery aneurysms with low-profile visualized intraluminal support device. BMC Neurology. 21(1). 198–198. 3 indexed citations

12.

Jiang, Peng, Yu Zhang, Beibei Ru, et al.. (2021). Systematic investigation of cytokine signaling activity at the tissue and single-cell levels. Nature Methods. 18(10). 1181–1191. 115 indexed citations

13.

Shi, Sailing, Shengqing Gu, Wubing Zhang, et al.. (2020). Inhibition of MAN2A1 Enhances the Immune Response to Anti–PD-L1 in Human Tumors. Clinical Cancer Research. 26(22). 5990–6002. 45 indexed citations

14.

Bagati, Archis, Sushil Kumar, Peng Jiang, et al.. (2020). Integrin αvβ6–TGFβ–SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast Cancer. Cancer Cell. 39(1). 54–67.e9. 136 indexed citations

15.

Hu, Xihao, Jian Zhang, Jin Wang, et al.. (2019). Landscape of B cell immunity and related immune evasion in human cancers. Nature Genetics. 51(3). 560–567. 104 indexed citations

16.

Pan, Deng, Aya Kobayashi, Peng Jiang, et al.. (2018). A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing. Science. 359(6377). 770–775. 567 indexed citations breakdown →

17.

Jiang, Peng, Winston Lee, Jun S. Liu, et al.. (2018). Genome-Scale Signatures of Gene Interaction from Compound Screens Predict Clinical Efficacy of Targeted Cancer Therapies. Cell Systems. 6(3). 343–354.e5. 41 indexed citations

18.

Mei, Shenglin, Clifford A. Meyer, Rongbin Zheng, et al.. (2017). Cistrome Cancer: A Web Resource for Integrative Gene Regulation Modeling in Cancer. Cancer Research. 77(21). e19–e22. 106 indexed citations

19.

Lin, Li, et al.. (2012). [Association between -590C/T polymorphisms of interleukin-4 gene and chronic periodontitis: a meta-analysis].. PubMed. 21(5). 550–5. 1 indexed citations

20.

Pane, Attilio, Peng Jiang, Dorothy Yanling Zhao, Mona Singh, & Trudi Schüpbach. (2011). The Cutoff protein regulates piRNA cluster expression and piRNA production in the Drosophila germline. The EMBO Journal. 30(22). 4601–4615. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact